CVS Health Corporation (CVS)
Events leading up to CVS Health CEO Lynch's departure
CVS Health CEO Karen Lynch is stepping down after nearly four years at the helm, as the healthcare conglomerate faces shareholder pressure to improve its business performance.
CVS ousts CEO amid tanking shares, activist pressure: ‘Brewing for some time'
Shares are down by nearly half from their 2022 highs, in part due to repeated profit forecast cuts related to rising costs in its large healthcare insurance business and competition for its vast network of retail pharmacies.
CVS Health Stock Slips on C-Suite Shakeup
CVS Health Corp (NYSE:CVS) stock is down 7.3% at $59.04 at last glance, after news that the company has replaced CEO Karen Lynch with pharmacy benefits executive David Joyner.
CVS shakeup: Stock tumbles on abrupt news that David Joyner will replace CEO Karen Lynch
One of the nation's largest healthcare companies is experiencing a seismic shakeup.
CVS Stock Plummets as It Replaces CEO
CVS Health (CVS) stock tumbled about 7% in morning trading Friday after the pharmacy and healthcare giant announced the replacement of Chief Executive Officer (CEO) Karen Lynch with David Joyner, a longtime company veteran who most recently ran Caremark, its pharmacy benefit manager (PBM).
CVS Replaces CEO With Caremark President David Joyner
CVS has replaced CEO Karen Lynch as it struggles to repair its healthcare business. David Joyner, president of the company's pharmacy benefit management unit Caremark, has been appointed as the new chief executive, CVS announced Friday (Oct. 18).
CVS Ousts CEO Lynch, Names David Joyner as New Chief
CVS Health Corp. named David Joyner as its new chief executive officer, ending a tumultuous tenure for Karen Lynch. Joyner took over Thursday, according to a Friday release.
CVS names David Joyner new CEO, replacing Karen Lynch
CVS Health tapped industry veteran David Joyner to become CEO and turnaround the struggling business.
CVS Health shares slump on CEO change, disappointing profit guidance
CVS Health Corp (NYSE:CVS) shares plunged more than 7% in early trade as the pharmaceutical chain announced it is replacing its CEO Karen Lynch with company veteran David Joyner, effective immediately. Joyner has most recently served as executive vice president of CVS Health and president of CVS Caremark, bringing 37 years of health care and pharmacy benefit management experience, CVS said on Friday.
CVS Shares Fall 10% After Replacing CEO—Lowering Earnings Projections
Shares of CVS dropped by 10% on Friday morning, pacing what would be the company's worst loss in three years, after the company replaced its chief executive while cutting its earnings projections well below analyst expectations.
CVS replaces CEO Karen Lynch with exec David Joyner as profits, share price suffer
CNBC's Joe Kernen reports on the latest news.
CVS Stock Plummets as It Replaces CEO
CVS Health (CVS) stock tumbled 10% Friday morning after the pharmacy and healthcare giant announced the replacement of Chief Executive Officer (CEO) Karen Lynch with David Joyner, a longtime company veteran who most recently ran Caremark, its pharmacy benefit manager (PBM).
